Matters of the heart: the case of TNFalpha-targeting drugs

Mol Interv. 2011 Apr;11(2):79-87. doi: 10.1124/mi.11.2.4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy
  • Cardiotonic Agents / antagonists & inhibitors
  • Cardiotonic Agents / immunology
  • Cardiotonic Agents / metabolism
  • Cardiotonic Agents / therapeutic use
  • Heart / drug effects*
  • Heart / physiology
  • Heart / physiopathology
  • Heart Diseases / chemically induced
  • Heart Diseases / complications
  • Heart Diseases / drug therapy
  • Heart Diseases / metabolism*
  • Humans
  • Mice
  • Molecular Targeted Therapy* / adverse effects
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Cardiotonic Agents
  • Tumor Necrosis Factor-alpha